KNSA vs ZBRA · P/E 53, rev $677.6M vs P/E 28, rev $3.05B
Kiniksa Pharmaceuticals Ltd (KNSA) versus Zebra Technologies Corporation (ZBRA) — a side-by-side from cached financials, not a winner call.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
Zebra Technologies Corporation (ZBRA) is a communication equipment company listed on NASDAQ.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Latest reported ZBRA revenue for 2026-07-04 was $3.05B. Net income was $368.0M. ZBRA currently screens at market cap $11.10B and trailing P/E 28.1.
KNSA currently screens at market cap $3.73B and trailing P/E 53.2. ZBRA currently screens at market cap $11.10B and trailing P/E 28.1.
Not investment advice. Open the KNSA and ZBRA stock pages for the full models.
Not investment advice.